EXPLAINER: How To Live To 117

Alzheimer's research fraud: what happens when influential studies cannot be trusted? In this episode of Health Longevity Secrets, Robert Lufkin MD speaks with investigative journalist Charles Piller about research integrity, the amyloid hypothesis, and the human cost of unreliable science. We discuss Matthew Schrag's image analysis, the retracted 2006 Nature paper, simufilam, and why patients need both rigorous research and better care.Chapters:00:00 — Introduction01:40 — Charles Piller and the Origins of Doctored07:16 — Alzheimer's Disease and the Amyloid Hypothesis11:40 — Amyloid Research, Funding, and Scientific Gatekeeping14:49 — The Retracted Nature Paper and Amyloid-Beta Star 5619:55 — Simufilam, Cassava Sciences, and Patient Opportunity Costs24:07 — Stroke Research and the Berislav Zlokovic Investigation27:10 — How Scientists Detect Manipulated Research Images30:40 — Research Misconduct Beyond Alzheimer's Disease33:14 — Exploring Infection, Inflammation, and GLP-1 Research35:56 — Brain Health: Prevention and Care Alongside Cure37:40 — Publish or Perish: Changing Scientific Incentives41:22 — NIH, FDA, and Accountability in Science44:07 — Responses to Doctored and Scientific Criticism46:26 — Reasons for Hope, Guest Resources, and ClosingKEY TAKEAWAYS:A retracted paper must not be treated as reliable supporting evidence.Piller argues that research incentives can discourage challenges to established ideas.Failed trials can carry substantial opportunity costs for patients and families.Scientific skepticism should lead to stronger evidence, not blanket distrust.Care and prevention deserve attention alongside the search for treatments.IMPORTANT CONTEXT:The episode presents Piller's reporting and interpretations; allegations are not the same as established findings. The 2006 Nature paper was retracted in 2024. That retraction does not by itself disprove every role for amyloid in Alzheimer's disease. Some anti-amyloid treatments slow decline in selected patients; slowing decline is not stopping or reversing the disease, and treatment carries risks.STUDIES & SOURCES DISCUSSED:Charles Piller / Doctored: https://charlespiller.com/Piller's Science investigation, "Blots on a field?": https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-diseaseLesne et al., Nature 2006 (RETRACTED): https://pubmed.ncbi.nlm.nih.gov/16541076/Nature's 2024 retraction notice: https://www.nature.com/articles/s41586-024-07691-8Science reporting on Zlokovic and the stroke trial: https://www.science.org/content/article/top-alzheimer-s-researcher-goes-leave-amid-misconduct-concernsADDITIONAL CONTEXT:Published phase 3 simufilam results: https://pmc.ncbi.nlm.nih.gov/articles/PMC12988371/FDA Leqembi prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761269s011lbl.pdfSubscribe for more evidence-based health conversations.Robert Lufkin MD's book, Lies I Taught in Medical School: https://robertlufkinmd.com/lies/Newsletter: https://robertlufkinmd.substack.comWebsite: https://robertlufkinmd.com#Alzheimers #MetabolicHealth #HealthLongevitySecrets⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

On October 28, 2026, HHS said it will allow pharmacies to compound six popular peptides: BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon. Not one of them is FDA approved, and the Associated Press reported that FDA scientists opposed the change. In this episode, Robert Lufkin MD explains what the policy actually allows, the conditions pharmacies have to meet, and what the human evidence shows for each of the six peptides. He also covers the risks and three questions to ask before considering any compounded peptide.In this episode:(00:00) Six peptides get a green light(00:45) What actually changed(02:08) The fine print(02:58) BPC-157 and TB-500(04:08) KPV, Semax, and Epitalon(05:02) MOTS-c and the metabolic root(05:53) The honest caveat(07:02) The takeawayWatch the video: https://youtu.be/kX8PD65-hZoKey sources:- BakerHostetler policy summary: https://www.bakerlaw.com/insights/hhs-issues-enforcement-discretion-policy-regarding-503a-compounding-using-certain-peptide-bulk-drug-substances/- AP News: https://apnews.com/article/peptides-fda-rfk-compounding-8da016068c004486159514d3a7471fd7- Poolton JT et al., Acta Orthop Belg 2026: https://doi.org/10.52628/92.3.15837- Ruff D et al., Ann N Y Acad Sci 2010: https://doi.org/10.1111/j.1749-6632.2010.05474.x- Al-Dulaimi S et al., Biogerontology 2025: https://doi.org/10.1007/s10522-025-10315-x- Lee C et al., Cell Metab 2015: https://doi.org/10.1016/j.cmet.2015.02.009Full source list in the YouTube description.Educational content only, not medical advice.Robert Lufkin MD | https://www.robertlufkinmd.com⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Inside every one of your cells live tiny ancient bacteria called mitochondria. When they fail, and they fail decades before you feel sick, they drive cancer, Alzheimer's, heart disease and diabetes. Here's how they fail, and how to rebuild them without drugs. Chapters00:00 Introduction00:33 What mitochondria actually are02:01 The four ways mitochondria fail03:56 The diseases this explains05:34 How to rebuild your mitochondria07:35 The bottom line Key takeawaysMitochondria decide whether a cell lives or dies, control inflammation, sense nutrients and regulate hormones.They fail in four ways: oxidative damage, DNA mutations, dysfunction, and failed cleanup (mitophagy).Broken mitochondria release DNA fragments that trigger the cGAS-STING pathway and chronic low-grade inflammation.What rebuilds them: Zone 2 cardio, high-intensity intervals, time-restricted eating, cold and heat, good sleep, and avoiding what poisons them. StudySeyfried TN et al. The metabolic theory of cancer. J Bioenerg Biomembr 2025;57:57-83. https://doi.org/10.1007/s10863-025-10059-w Music: Epidemic Sound. Watch the video: https://youtu.be/61PbwUZtvt8Book: Lies I Taught in Medical School https://robertlufkinmd.com/lies/Substack: https://robertlufkinmd.substack.com/ Robert Lufkin MD | Health Longevity Secrets. For education only, not medical advice. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Elizabeth Holmes went to prison for promising hundreds of blood tests from a single drop of your finger. Some of what she promised is now FDA cleared, and some of it may never be possible at all. With the new documentary You Can See Everything in theaters, Robert Lufkin MD looks at what Theranos promised, what really happened, what is actually FDA cleared in 2026, the physics of a single drop, and which home and finger-stick tests you can trust.Watch the video: https://youtu.be/CjpbudYdV1ISources- U.S. SEC, Theranos, CEO Holmes, and Former President Balwani Charged With Massive Fraud (Mar 14, 2018): https://www.sec.gov/newsroom/press-releases/2018-41- U.S. Attorney's Office, N.D. Cal., U.S. v. Elizabeth Holmes, et al.: https://www.justice.gov/usao-ndca/us-v-elizabeth-holmes-et-al- DOJ, Elizabeth Holmes Sentenced To More Than 11 Years For Defrauding Theranos Investors (Nov 18, 2022): https://www.justice.gov/usao-ndca/pr/elizabeth-holmes-sentenced-more-11-years-defrauding-theranos-investors-hundreds- Walgreens, Walgreens Terminates Relationship with Theranos (2016): https://corporate.walgreens.com/news-and-stories/press-releases/2016/walgreens-terminates-relationship-with-theranos-will-be-closing-operations-at-all-40-theranos-wellness-centers-in-arizona/- AP, Feds ban Theranos CEO Holmes from running lab for 2 years (2016): https://apnews.com/general-news-16add2a7397b47cca3e8bb463e037526- FDA 510(k) K230391, BD MiniDraw SST (cleared Dec 1, 2023): https://www.accessdata.fda.gov/cdrh_docs/pdf23/K230391.pdf- FDA 510(k) K230493, BD MiniDraw H&H: https://www.accessdata.fda.gov/cdrh_docs/reviews/K230493.pdf- FDA 510(k) K221131, Tasso+ (cleared Aug 12, 2022): https://www.accessdata.fda.gov/cdrh_docs/pdf22/K221131.pdf- FDA, FDA Clears First Over-the-Counter Continuous Glucose Monitor (Mar 5, 2024): https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor- Bond MM, Richards-Kortum RR. Drop-to-Drop Variation in the Cellular Components of Fingerprick Blood. Am J Clin Pathol 2015;144:885-894: https://doi.org/10.1309/AJCP1L7DKMPCHPEH- Jacobsen LM et al. Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests. Diabetes Technol Ther 2022;24(11):789-796: https://doi.org/10.1089/dia.2022.0187- You Can See Everything (A24, 2026), AP coverage: https://apnews.com/article/nathan-fielder-elizabeth-holmes-documentary-film-premiere-cc89d956b120a0f7035d044e4c6bb3d6Visual credits- Product images (Part 5): Theranos miniLab, Fig. 2A from Nourse MB et al., Bioeng Transl Med 2018;3(1):58-70, PMC5773944, CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/), cropped; Tasso+ image: Tasso, Inc. (tassoinc.com); Stelo image: Dexcom (stelo.com); BD MiniDraw image: BD (Becton, Dickinson and Company) press release, Dec 7, 2023. Company images used with credit; trademarks belong to their owners.- Article card (Part 5): headline and abstract excerpt from Jacobsen LM et al., Diabetes Technol Ther 2022;24(11):789-796, doi:10.1089/dia.2022.0187- Screen captures of U.S. government pages (SEC, U.S. Department of Justice, FDA press announcement, FDA 510(k) letters K230391 and K221131) are U.S. government works in the public domain.- Charts, timeline, checklist and the fingertip-drop animation are original graphics by Robert Lufkin MD, drawn from the sources above.- Film excerpts: You Can See Everything (A24, 2026), dir. Nathan Fielder and Lance Oppenheim. Short clips from the Official Trailer (https://www.youtube.com/watch?v=HvW_N5p1q44) and Official Teaser (https://www.youtube.com/watch?v=GGJSRFWALTI), used for commentary and criticism. Not affiliated with or endorsed by A24 or the filmmakers.Photo: Max Morse for TechCrunch, CC BY 2.0, via Wikimedia Commons (cropped/edited).Educational content only. This is not medical advice. Talk with your own healthcare provider before making changes to your health.⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A young scientist died in a Russian plague lab. Officials deny an accident. Is biowarfare a real threat, or is the bigger risk something else? Robert Lufkin MD looks at the death of a young lab worker at Russia's Irkutsk anti-plague institute, why Moscow's denials are hard to take at face value, and what Annie Jacobsen's book Biological War: A Scenario gets right and wrong. Untreated pneumonic plague is almost always fatal. The right antibiotics cut deaths sharply. A strain that shrugs off those drugs is the real nightmare. Historically, the bigger risk has been accidents, secrecy, and a slow response, not a deliberate attack. Chapters: 00:00 — Introduction 00:41 — What Happened at the Irkutsk Plague Lab 01:54 — Why the World Doesn't Take Russia's Word 03:09 — Satellite Images of Russia's Expanding Biolabs 03:25 — Annie Jacobsen's Biological War Scenario 04:48 — Untreated Plague Is Almost Always Fatal 05:31 — Madagascar's Drug-Resistant Plague Strain 05:50 — Lab Accidents Are More Likely Than Attacks 06:29 — The 2019 Fire at Russia's Vector Lab 06:48 — The Takeaway: Chronic Disease Was the Real Risk Key takeaways: A young scientist died of pneumonia of unknown origin at a Siberian plague lab. Independent reports alleged a broken tube of live plague. Russian authorities deny a lab accident. In 1979, spores leaked from a Soviet military bioweapons facility. Moscow blamed bad meat for 13 years. Satellite images show 10 new buildings and more than 250,000 square feet added at a Russian biological facility since 2022. Untreated pneumonic plague is almost always fatal. In a CDC review, antibiotics cut deaths to about 17 percent with the right drugs. In 1995, doctors in Madagascar found a plague strain resistant to every antibiotic then recommended. Lab accidents, secrecy, and slow response have been the larger historical risk, including a 2019 fire at the Vector lab. In the COVID data cited here, nearly 95 percent of hospitalized adults already had a chronic condition. Studies & sources: Nelson et al., Clinical Infectious Diseases, 2020 Galimand et al., New England Journal of Medicine, 1997 Kompaniyets et al., Preventing Chronic Disease, 2021 CNN, October 4, 2026 The Atlantic on the 1979 Sverdlovsk anthrax leak Washington Post on Russia's laboratory expansion The Conversation on Annie Jacobsen, Biological War: A Scenario CNN on the 2019 Vector lab fire Dr. Lufkin's book Lies I Taught in Medical School. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

She lived to 117 — and when scientists sequenced everything from her genome to her gut bacteria, they found a paradox that rewrites what aging has to look like. In this episode, Robert Lufkin MD breaks down the landmark multiomics study of Maria Branyas Morera, the world's oldest verified person, published in Cell Reports Medicine (2025) by the Esteller lab. The study mapped her genome, epigenome, proteome, metabolome, and microbiome — and found a body that was simultaneously very old and biologically young.Chapters:00:00 — Introduction00:43 — Who Was Maria Branyas Morera, the World's Oldest Person?01:18 — The Multiomics Study Published in Cell Reports Medicine02:03 — The Paradox: Old and Young at the Same Time02:23 — Epigenetic Clocks: A Biological Age 23 Years Younger02:51 — Why Her Short Telomeres May Have Protected Her03:44 — Clean Metabolism: Very Low Triglycerides, High HDL04:22 — Inflammaging: Why Low Inflammation Is the Real Headline05:10 — Gut Microbiome, Daily Yogurt, and Bifidobacterium06:05 — The Longevity Chain: Gut, Inflammation, Metabolism06:23 — The Honest Caveat: Half Genetics, Half Lifestyle07:29 — The Takeaway: What Aging Cleanly Really MeansKey takeaways:Six epigenetic clocks estimated her biological age as much as 23+ years younger than her chronological ageHer telomeres were among the shortest recorded in a healthy person — possibly acting as a brake on tumor growth rather than a death sentenceHer lipid panel was remarkably clean: extremely low VLDL and triglycerides, very high HDLSystemic inflammation stayed strikingly low — "inflammaging" was turned downHer gut microbiome was unusually diverse and dominated by Bifidobacterium — she ate about three yogurts a day for the last 20 years of her lifeIt's an n-of-1 study: roughly half genetics, half lifestyle — but the pattern points upstream to metabolic healthStudies & sources mentioned:Santos-Pujol et al., Cell Reports Medicine 2025 — The multiomics blueprint of the individual with the most extreme lifespanWatch the video version on YouTube: https://youtu.be/0TX_E46sAFk📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Substack newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

A facial plastic surgeon reveals the MRI data on "Ozempic face," why repeated masseter Botox can thin the jawbone, and the topical rapamycin resetting skin cells to a 20-year-old phenotype.In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Dr. Kay Durairaj, a USC and UCLA-trained facial plastic surgeon bringing evidence-based medicine to the longevity-aesthetics frontier. Old friends from their UCLA head and neck tumor-board days, they dig into the science most aesthetic clinics gloss over: how GLP-1 drugs uniquely strip facial fat, why exosomes and peptides are a "Wild West," the surprising data on retinoids and epigenetic aging, and how collagen biostimulators and topical rapamycin may genuinely rejuvenate skin at the cellular level.Chapters:00:00 — Introduction02:03 — From Head & Neck Cancer Surgery to Longevity Aesthetics03:04 — Bringing Evidence-Based Medicine to the Aesthetics Wild West04:06 — Why Aging Should Be Treated as a Disease06:07 — Ozempic Face: The MRI Data on Facial Fat Loss09:14 — The Mid-Face Miracle Protocol: Collagen Biostimulators10:15 — Reversing Ozempic Face After Rapid Weight Loss11:15 — Exosomes Explained: Real Biology vs Marketing Hype14:18 — How to Vet Exosome Sourcing, Purity and Shelf Life16:22 — The Peptide Wild West: BPC-157, SS-31 and FDA-Approved Options19:28 — N-of-1 Peptide Risks: Angiogenesis and Oncogenes20:28 — Do Retinoids Accelerate Aging? The MitraBio Epigenetic Data23:32 — Sculptra and Radiesse: Real Regenerative Science25:33 — Masseter Botox and Permanent Jawbone Thinning29:37 — Three Facial Biomarkers of Biological Age31:38 — Does Lifting Weights Help or Hurt Your Face?36:48 — Topical Rapamycin: Resetting Fibroblasts to a 20-Year-Old40:51 — A New Peptide Skin-Longevity Line and Final AdviceKey takeaways:GLP-1 drugs uniquely attack facial fat — MRI data show roughly 7% midfacial volume loss for every 10 kg of weight lost, primarily from superficial and deep cheek fat pads, driving "Ozempic face."Collagen biostimulators (like Sculptra and Radiesse) can preserve or restore facial volume during rapid weight loss and have 20+ years and 200+ peer-reviewed papers behind their collagen-remodeling effects.The exosome and research-peptide markets are largely unregulated — source, purity, shelf life, and donor quality matter, and lyophilized "exosome" skincare is often just protein fragments.Repeated masseter Botox can thin the mandibular bone, especially in postmenopausal women — animal data are consistent, human data are mixed, so caution is warranted with aggressive long-term use.Topical rapamycin (a "rapalog") may reset the fibroblast mTOR cycle, shifting aged, bloated skin cells toward a younger, spindle-shaped phenotype — an emerging frontier in cellular skin rejuvenation.Studies & sources:Radiographic Midfacial Volume Changes in Patients on GLP-1 Agonists (7% loss per 10 kg) — https://pubmed.ncbi.nlm.nih.gov/40407186/Soft Tissue Facial Changes Following Massive Weight Loss, Aesthetic Surgery Journal Open Forum 2024 — https://pmc.ncbi.nlm.nih.gov/articles/PMC11427949/MitraBio epigenetic skin DNA-methylation tape-strip profiling — https://mitrabio.tech/resources/unlocking-epigenetic-insights/Repeated botulinum toxin masseter injections decrease mandibular angle bone volume — https://pmc.ncbi.nlm.nih.gov/articles/PMC5466904/RapaLogic / Re-Q topical rapalog for fibroblast skin rejuvenation — https://www.rapamycin.news/t/a-new-rapalog-for-skin-aging-rapalogix-health-rlx-201/22010GHK-Cu copper peptide: regenerative and protective actions in skin — https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/Dr. Kay Durairaj — Beauty by Dr. Kay — https://beautybydrkay.com/📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Will AI cure all disease? 90% of biomedical papers published in December 2025 show signs of AI assistance — and the Nobel laureate behind AlphaFold says AI could help end all disease within a decade. In this episode, Robert Lufkin MD examines what artificial intelligence is really doing to health science: the quiet takeover of the scientific paper, the first AI-discovered drug to pass a Phase 2a trial, robot laboratories running experiments around the clock, and the honest caveats behind the "end of disease" headlines — plus what it all means for your health today. Chapters: 00:00 — The 90% Stat: AI Fingerprints in Biomedical Papers 00:49 — Part 1: The Quiet Takeover of the Scientific Paper 02:16 — Part 2: The Wins Are Real 02:46 — AlphaFold, 200 Million Proteins & the 2024 Nobel Prize 03:13 — Rentosertib: First AI-Discovered Drug to Pass Phase 2a 04:02 — The Superbug Puzzle: 10 Years vs 2 Days 04:22 — Part 3: Robot Labs & the 10-Year Promise 05:26 — Demis Hassabis on "The End of Disease" 06:26 — Part 4: The New Bottleneck Is Verification 07:43 — Part 5: The Honest Caveats 08:42 — Part 6: The Takeaway Key takeaways: Roughly 90% of biomedical papers published in December 2025 show measurable signs of AI writing assistance — most of it polishing, not fraud. AlphaFold predicted structures for essentially all 200 million known proteins and earned the 2024 Nobel Prize in Chemistry. Rentosertib became the first drug with an AI-discovered target and AI-designed molecule to improve lung function in a randomized, placebo-controlled Phase 2a trial (Nature Medicine). Autonomous "robot labs" like Lila Sciences ($1.3B valuation, backed by Nvidia) aim to run science at machine speed. The bottleneck in science is shifting from producing findings to verifying them — zero AI-discovered drugs have full FDA approval so far. No matter how fast discovery gets, your metabolic health remains the foundation AI can't replace. Studies & sources: Kobak et al. — Detecting AI fingerprints in biomedical abstracts (preprint) Nature News — AI-written biomedical literature Nobel Prize in Chemistry 2024 — AlphaFold Rentosertib Phase 2a randomized trial, Nature Medicine 2025 BBC News — Imperial College superbug question answered by AI in 2 days Fierce Biotech — Lila Sciences autonomous AI research labs Lila Sciences — $1.3B valuation with Nvidia backing CBS 60 Minutes — Demis Hassabis on "the end of disease" 📖 Dr. Lufkin's book "Lies I Taught in Medical School" ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

Modern technology is tricking your nervous system into fight-or-flight — and it's decently profitable to keep you there. Jon Hacker, CEO of NeurGear, explains how focused ultrasound vagus nerve stimulation can switch you back.In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Jon Hacker, biomedical engineer and CEO/co-founder of NeurGear, the company behind ZenBud — the first ultrasound-based vagus nerve stimulator. They cover how the vagus nerve governs your rest-and-digest state, why so many of us are stuck in survival mode, how ultrasound compares to electrical stimulators, what the clinical trial data shows, and where single-neuron interfaces could take medicine next.Chapters:00:00 — Introduction01:36 — From Anime Dream to Neurotech Startup: Jon Hacker's Story06:32 — How AI Supercharges a Small Hardware Team09:26 — Why Ultrasound Won: Two Pivots to the Vagus Nerve12:21 — Vagus Nerve 101: Rest-and-Digest vs Survival State14:59 — How Modern Technology Traps You in Fight-or-Flight16:02 — Measuring Vagal Tone: HRV, Resting Heart Rate & Reaction Time19:44 — How Focused Ultrasound Activates a Nerve21:07 — ZenBud vs Electrical Vagus Stimulators (Pulsetto, Truvaga)23:00 — Dosing ZenBud: 30-Minute Sessions, Sleep & Safety Limits26:05 — The Medical Industry's Incentive Problem30:16 — What to Track: Why Quality of Life Beats Biometrics32:34 — Side Effects & Overuse: Headache Warning Signs34:22 — Where VNS Fits: Sleep, Diet, Exercise & Breathwork36:57 — The Future: Single-Neuron Interfaces & Full-Dive VRKey takeaways:Your vagus nerve drives your "rest-and-digest" state — low vagal tone leaves you stuck in survival mode, and chronic survival-state activation feeds the chronic diseases we face todayZenBud uses low-intensity focused ultrasound (not electricity) to stimulate the auricular branch of the vagus nerve — no shocks, no gel pads, no app requiredIn a 4-week pilot trial, daily 5-minute sessions produced significant reductions in anxiety, depression, and PTSD symptom scoresReaction time, resting heart rate, and HRV can track nervous-system changes — but your quality of life is the gold standardStart with 5 minutes a day and scale up slowly; a mild reversible headache is the signal to dial backStudies & sources:Kohler I, Hacker J, Martin E — "Reduction of Anxiety-Related Symptoms Using Low-Intensity Focused Ultrasound Neuromodulation" (JMIR Neurotechnology, 2025) — https://neuro.jmir.org/2025/1/e69770Auricular Ultrasonic Vagus Nerve Stimulation (review, PMC) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12468173/ZenBud device — https://zenbud.healthNeurGear — https://neurgear.com📖 Dr. Lufkin's book Lies I Taught in Medical School · 📰 Substack newsletter · 🌐 robertlufkinmd.com⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/

For the first time in history, a personalized mRNA cancer vaccine has passed a Phase 3 clinical trial. Robert Lufkin MD breaks down the Moderna/Merck melanoma result, how a vaccine custom-built from your own tumor actually works, the 49% drop in recurrence risk behind the headlines — and the honest answer to whether mRNA vaccines will cure cancer. In this episode of Health Longevity Secrets, Robert Lufkin MD explains the science of personalized mRNA cancer vaccines: neoantigens, the AI-designed "most wanted poster" for your immune system, the five-year KEYNOTE-942 data, the stunning pancreatic cancer signal from Memorial Sloan Kettering, the BioNTech colorectal trial shutdown that reminds us why we run trials — and what still sits upstream of it all: your metabolic health. Chapters: 00:00 — Introduction: A Cancer Vaccine Makes History 00:43 — What Just Happened: Moderna/Merck Phase 3 Melanoma Trial 01:44 — A Vaccine Made From Your Own Tumor: How It Works 02:31 — Neoantigens: A "Most Wanted Poster" for Your T-Cells 03:17 — The Numbers Behind the Hype: 49% Lower Recurrence at 5 Years 03:53 — Pancreatic Cancer Vaccine: The Sloan Kettering Survival Signal 04:44 — So Will mRNA Vaccines Cure Cancer? The Honest Answer 05:40 — The Platform Play: Lung, Kidney & Prostate Cancer Trials 06:09 — The Honest Caveats: Press Releases vs Peer Review 06:45 — The Colorectal Trial Shutdown: A Reality Check 07:57 — The Takeaway: Metabolic Health Still Sits Upstream Key takeaways: Intismeran autogene + Keytruda is the first mRNA cancer vaccine to succeed in a Phase 3 trial — FDA approval possibly by early 2027. These are NOT prevention shots — each dose is custom-built from one patient's tumor mutations to hunt residual cancer cells after surgery. Five-year Phase 2b data (KEYNOTE-942): 49% lower risk of recurrence or death, and 62% lower risk of distant metastasis or death at three years. Pancreatic trial (n=16): ~90% of immune responders alive 4–6 years after surgery vs ~25% of non-responders — hypothesis-generating, not proof. The reality check: BioNTech/Genentech halted a colorectal Phase 2 after MORE deaths in the vaccine-alone arm — same technology, different cancer, opposite result. The Phase 3 result is a top-line press release, not yet peer-reviewed; the vaccine is not FDA-approved and is only available in clinical trials today. Muscle, blood sugar control, sleep, not smoking, and sun protection remain the most proven cancer-risk tools you own right now. Studies & sources: Merck/Moderna press release (Aug 19, 2026) — Phase 3 INTerpath-001: intismeran autogene + Keytruda met RFS & DMFS endpoints Nature news — Personalized Moderna/Merck mRNA vaccine reduces melanoma recurrence in Phase 3 Weber et al., J Clin Oncol 2026 — 5-Year Update of KEYNOTE-942 (49% recurrence/death reduction) Rojas et al., Nature 2023 — Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (MSK) BioNTech statement (Aug 28, 2026) — Phase 2 colorectal trial of autogene cevumeran terminated ABC News — Personalized mRNA cancer vaccine shows promise Dr. Lufkin's book Lies I Taught in Medical School — more at robertlufkinmd.com and the Health Longevity Brief on Substack. ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!New episodes every other Tuesday. Subscribe so you don't miss one.Continue this conversation on Substack: https://robertlufkinmd.substack.comLies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/Web: https://www.robertlufkinmd.comYouTube: https://www.youtube.com/robertlufkinmdX: https://x.com/robertlufkinmdInstagram: https://www.instagram.com/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinLinkedIn: https://www.linkedin.com/in/robertlufkinmd/